Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
ClinicalTrials.gov study NCT01341639. IPD Sharing: YES. Countries: 0. Publications: 1.
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
ClinicalTrials.gov study NCT00971100. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers
ClinicalTrials.gov study NCT01484600. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
ClinicalTrials.gov study NCT03392064. IPD Sharing: YES. Countries: 1. Publications: 1.
Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care
ClinicalTrials.gov study NCT02324933. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)
ClinicalTrials.gov study NCT04516213. IPD Sharing: NO. Countries: 1. Publications: 1.
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
ClinicalTrials.gov study NCT00816660. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
ClinicalTrials.gov study NCT00000756. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
ClinicalTrials.gov study NCT02609022. IPD Sharing: NO. Countries: 1. Publications: 2.
Specific Oral Tolerance Induction in Children Allergic to Cow's Milk Proteins
ClinicalTrials.gov study NCT01641731. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease
ClinicalTrials.gov study NCT04685265. IPD Sharing: NO. Countries: 1. Publications: 6.
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
ClinicalTrials.gov study NCT01506271. IPD Sharing: YES. Countries: 0. Publications: 1.
The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
ClinicalTrials.gov study NCT03255993. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation
ClinicalTrials.gov study NCT01279538. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
ClinicalTrials.gov study NCT01893190. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT01679587. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
ClinicalTrials.gov study NCT00171106. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis
ClinicalTrials.gov study NCT05153148. IPD Sharing: YES. Countries: 4. Publications: 0.
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
ClinicalTrials.gov study NCT02910258. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
ClinicalTrials.gov study NCT00909025. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.